Anticipated Release Date: Q4FY24
Prophylactic and therapeutic medical countermeasures for exposure to naturally occurring, synthetic and/or aerosolized toxins (excluding botulinum and ricin). Efforts would aim to focus on advancing the discovery of: Enabling capabilities for activity (i.e., potency) and characterization assays, animal models and related hurtles in development, Identification of toxin and/or host-based targets common to toxin families, and platforms for discovery and evaluation of broad-spectrum countermeasures focused on targeting mechanism of action.
Responding to this opportunity requires membership in the Medical CBRN Defense Consortium. This Consortium releases numerous solicitations throughout the year, so even if this opportunity may not end up being right for you, we strongly encourage you to join, so you are ready for the next opportunity.
Complete the form below and a program representative will reach out to you shortly to support you through the process.